Trial reportEye (London, England)2024
Quality of vision clinical outcomes for a new fully-refractive extended depth of focus Intraocular Lens.
Trial report in Eye (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Comparison of visual outcomes of enhanced monofocal versus conventional monofocal intraocular lenses: a meta-analysis of randomized controlled trials.International ophthalmology · 2026Pooled it
- Meta-analysis of defocus curves of monofocal, enhanced monofocal and extended depth of focus IOLs.BMJ open ophthalmology · 2025Pooled it
- Clinical Performance After Implantation of a New Purely Refractive Extended Depth of Field Intraocular Lens in Cataract Patients.Clinical ophthalmology (Auckland, N.Z.) · 2026Trial
- Tolerance to refractive error with a new extended depth of focus intraocular lens.Eye (London, England) · 2024Trial
- Clinical outcomes of a new presbyopia-correcting intraocular lens with spiral optic.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Review
- Patient-reported outcome measures after non-diffractive extended range of field IOL implantation: PureSee versus Vivity.Acta ophthalmologica · 2026Article
- An Update on Intraocular Lens Technology for Presbyopia Correction and Visual Outcomes.Medical sciences (Basel, Switzerland) · 2026Review
- Visual function comparison of a non-diffractive extended depth-of-focus and an enhanced monofocal intraocular lens sharing the same platform.Scientific reports · 2026Article
- Visual Quality in Acute Retinal Pigment Epitheliitis: A Case Report.Reports (MDPI) · 2026Article
- Comparative Photopic and Mesopic Visual Performance of Enhanced Monofocal Versus Non-Diffractive Extended Depth-of-Focus Intraocular Lenses.Journal of clinical medicine · 2026Article
- Higher-order aberrations and visual outcomes of a new refractive extended depth-of-focus intraocular lens with a target of slight myopia.Scientific reports · 2026Article
- Review
- Comparison of Clinical Outcomes After Cataract Surgery with Implantation of Either a Partial-Depth of Field Extended or Monofocal Intraocular Lens.Journal of clinical medicine · 2026Article
- Comparative Visual Performance and Optical Stability of Clareon Vivity and TECNIS PureSee EDoF IOLs in Cataract Patients.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Clinical outcomes of effectiveness and safety in cataract patients implanted with the novel hybrid extended depth-of-focus intraocular lens AM2UH: a prospective study.Frontiers in medicine · 2026Article
- Early Visual Performance and Subjective Experience After Bilateral Implantation of a Novel Fully Refractive Extended Depth of Focus Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Comparison of U.S. FDA premarket approval studies between two non-diffractive extended depth of focus lenses (AcrySof IQ Vivity versus TECNIS PureSee).Medical hypothesis, discovery & innovation ophthalmology journal · 2026Article
- A Retrospective Study: Comparative Visual Performance of Two Non-Diffractive Extended Depth-of-Focus Intraocular Lenses: TECNIS PureSee versus Clareon Vivity.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Factors that affect distance-corrected near visual acuity in partial range of focus intraocular lenses.Scientific reports · 2025Observational
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectiveTo evaluate the visual performance of a purely refractive extended depth of focus (EDF) intraocular lens (IOL). SUBJECTS/
methodsA prospective, multi-center, randomized, subject/evaluator-masked study. Subjects were bilaterally implanted with the EDF test (Model ZEN00V, TECNIS PureSee™ IOL, N = 60) or an enhanced monofocal control (Model ICB00, TECNIS Eyhance™ IOL, N = 57) IOL. Monocular corrected distance (CDVA), intermediate (DCIVA), near acuities (DCNVA) and patient reported visual symptoms were evaluated at the 6-month visit. Monocular mesopic contrast sensitivity (CS) and depth of focus (DOF) testing were assessed at 3 months.
resultsCDVA (Mean ± SD) was -0.06 ± 0.08 for test and -0.05 ± 0.08 logMAR for control groups. DCIVA was 0.13 ± 0.08 for test and 0.18 ± 0.14 logMAR for control groups (p = 0.0127). DCNVA was 0.37 ± 0.10 for test and 0.43 ± 0.16 logMAR for control groups (p = 0.0137). Test lens was statistically superior for intermediate and near. Overall, 91.7% (halos), 95.0% (starbursts) and 95.0% (glare) of test lens patients reported that they did not experience, were not bothered, or were slightly bothered by specific visual symptoms, compared to 98.2%, 100% and 96.5% in the control group. The DOF range over which monocular visual acuity was 0.20 logMAR or better was -1.6 D for the test lens. Mesopic CS was comparable between both groups, falling within 0.11 log units for all measured cycles per degree with and without glare.
conclusionThe EDF IOL demonstrated extended range of vision and statistically superior intermediate and near performance compared to the monofocal IOL. Distance visual acuity, contrast sensitivity and dysphotopsia profile were similar to the monofocal IOL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.